The Phreesia Story

Phreesia is the leader in patient check-in, with a network of thousands of clinicians nationwide. Started as the brain child of Chaim Indig and Evan Roberts in a 400-square-foot apartment in 2005, the company is headquartered in New York with operational support across the United States and in Ontario, Canada.

Acknowledging the changing environment of the healthcare industry and the mounting requirements for patient documentation, Chaim and Evan set out to simplify one of healthcare's most essential functions – the gathering of patient information. They saw an opportunity to save medical organizations time and money while enhancing the patient-doctor conversation. Leveraging their experience in the healthcare and software industries, they decided to revolutionize the traditional patient check-in process by eliminating the paper clipboard and automating patient intake. Chaim sketched the first touchscreen prototype on a napkin, and Phreesia was born. Chaim and Evan left the analytics firm where they were employed, moved from Boston to New York City, and successfully transitioned from co-workers to co-founders.

Phreesia makes it easy for clinicians to collect critical patient information, automatically verify eligibility and benefits, and collect patient payments at the point-of-care. In order to consistently develop and improve its service, Phreesia has ongoing relationships with prestigious medical and educational institutions, and receives continuous feedback from its rapidly growing network of medical practices.

Today, enhanced by the insight of its esteemed Medical Advisory Board and the wealth of knowledge from its Board of Directors, Phreesia enables clinicians to stay at the forefront of patient care and continues to attract energetic, top talent worldwide.

Executive Team

Since co-founding Phreesia in 2005, President and CEO Chaim Indig has established Phreesia as the premier patient check-in solution.  Under Chaim's leadership, Phreesia has established a nationwide clinical footprint, been used by millions of patients, worked with the world's largest healthcare companies, and raised $25 million from such investors as BlueCross BlueShield Venture Partners, Polaris Venture Partners, Sandbox Industries and HLM Venture Partners.

Prior to founding Phreesia, Chaim led the successful introduction of Spotfire, the leader in high-end analytics software, into the pharmaceutical sales and marketing space in the United States. Furthermore, he launched and established Spotfire as a recognized name in Canada.

Formerly, Chaim was an integral member of the original team at Olap@Work, the leader in SQL server front-end tools, which was successfully sold to Business Objects.

A frequent speaker, Chaim recently presented at McKinsey's Retail Healthcare Conference, Harvard Business School and MIT University, and is often quoted as an industry expert.  He has been recognized as a business leader by BusinessWeek, Inc. magazine, and Fox News.

As CTO and co-founder of Phreesia, Inc., Evan is the technical visionary responsible for driving Phreesia's initiative to pioneer patient self-service registration and educational solutions, at a low cost to clinicians in their medical practices.

Prior to founding Phreesia, Evan was a Senior Sales Engineer at Spotfire, a leading provider of interactive analytics software, where he helped to penetrate new markets including pharmaceutical sales and marketing, resulting in significant net new revenue. In that capacity he developed innovative applications, and trained and managed his team to support and nurture these new markets. He began his career at Spotfire as a member of the Professional Services team.

Evan holds a degree in Computer Engineering from Tufts University.

Rory Parness has spent nearly two decades working on the finance side of the media business. He came to Phreesia from MediaNet Digital – a B2B digital entertainment services provider, where he was the CFO. Rory is responsible for managing Phreesia's budgets and financial plans, in addition to the firm's financial reporting.

Jonathan came to Phreesia with 20-plus years of healthcare industry expertise and leads Phreesia's product marketing and clinical initiatives. Prior to joining Phreesia, Jonathan spent over six years as Vice President, Product Marketing, with NaviNet (formerly NaviMedix). In that capacity, he helped to create strategies and tactics that resulted in NaviNet's leadership in the automation of interactive communications between 300,000 healthcare providers and their business partners.

Previously, Jonathan held marketing and sales positions with Johnson & Johnson and Haemonetics Corporation (NYSE). He also worked for the Health Care Investment Banking Division of Alex. Brown & Sons and Goldman Sachs. Jonathan holds a MBA from Harvard Business School, and attended the Yale School of Medicine.

John has spent over 30 years working with emerging technology companies in a variety of sales, marketing and operational roles. He is responsible for building and supporting Phreesia's clinician network. Prior to joining Phreesia, John held VP-level positions with Cognos (recently purchased by IBM) and Jetform (acquired by Adobe). He has also been the CEO of a number of successful startups.

Nanette brings 17-plus years of healthcare sales and marketing experience, and she is responsible for nurturing and expanding Phreesia's client base. Prior to joining Phreesia, Nanette was Vice President of Business Development for TNS, the world's largest fully-integrated market research organization, where she launched and grew the brand and its advertising practices. Previously, Nanette was the top sales person at PharMetrics, a venture backed company, which was subsequently sold to IMS.

Board of Directors

Michael is President and CEO of Humedica, a next-generation clinical informatics company (www.humedica.com). Prior to launching Humedica, Michael served as Senior Managing Director at Leerink Swann, a leading health care investment bank. Previously, he was President and CEO of PHARMetrics, a health care informatics company, which was successfully sold to IMS Health in 2005. Michael has more than 25 years of executive management experience in the health care technology, information services, and consulting arenas. Michael received his MBA from Harvard Business School and his bachelor's degree in Economics from Brandeis University.

Edward L. Cahill is a Partner of HLM Venture Partners. Previously, Ed was a founding Partner of Cahill, Warnock & Company (now Camden Partners), a Baltimore venture capital firm, and a Managing Director of Alex. Brown & Sons, where he headed the firm's Health Care group from 1986 to 1995. During his leadership at Alex. Brown & Sons, the firm underwrote public offerings or provided merger advisory services for over 200 health care companies, including the first outpatient surgery, rehabilitation, and managed care companies to go public, and several leading biopharmaceutical companies. Ed is a director of Masimo Corporation, Phreesia and Prism Education Group. He previously served as a director of Animas Corporation, Centene Corporation (NYSE), Spinal Concepts and Automated Healthcare and Gene Medicine (NASDAQ). He is a Trustee of Johns Hopkins Medicine, The Johns Hopkins Hospital and Health System and Mercy Health Services.

Russell T. Ray is a Partner of HLM Venture Partners. Prior to joining HLM in 2003, Russ was a Managing Director and Global Co-Head of Health Care Investment Banking at Credit Suisse First Boston where he focused on providing strategic and financial advice to life sciences, health care services and medical device companies. Russ spent twelve years at Deutsche Bank and its predecessor entities, BT Alex. Brown and Alex. Brown & Sons, as a Managing Director and Global Head of Health Care Investment Banking. Russ began his career in investment banking in 1982 as a member of the High Technology and Emerging Growth Group at Merrill Lynch. During his investment banking career, Russ successfully completed over 175 merger and financing transactions for leading health care companies in the United States, Europe and Israel. Russ is a director of Allergan, Inc. (NYSE) and Phreesia and a Board Observer at Cbr Systems, Prism Education Group and Socios Mayores en Salud.

Alan brings more than 20 years of operating, strategy, and investment experience to Polaris.  He came to the firm from The Washington Post Company, where he worked for 18 years. During his career with The Post Company, he served as President, board member, Chief Financial Officer, President of Newsweek, head of newspaper marketing, and head of corporate business development.  The Post Company has significant activities in newspapers, educational markets (Kaplan), television, cable, and magazines.  At The Post Company, Alan also was responsible for early stage technology investments in cellular (Cellular One and digital PCS), distance learning and educational software, and information and e-commerce services (including Washingtonpost.com, Exchange.com, Junglee, BrassRing, Cars.com, and WebTV). Prior to The Washington Post, Alan was an officer at The Boston Consulting Group, an international management consulting firm specializing in corporate strategy.

Prior to joining Polaris, Bob served in product and business development roles at Envoy Networks where he assisted on product architecture decisions and co-developed the company's initial marketing strategy. Previous to Envoy Networks, Bob was with MCK Communications where he served as the Senior Director of Corporate Development and as a member of the executive team. His role included advising the President and CEO, managing business and product development relationships and building sales channels for the company's next generation products, and leading the company's initial public offering. Before MCK, Bob was an Associate at Summit Partners, a Boston-based private equity firm, where he focused on making investments in communications hardware and software companies and enterprise software businesses. He also served on the Board of Directors for Virtual Prototypes, a Montreal-based public software company.

Paul Brown is Vice President and Deputy General Counsel of the Blue Cross and Blue Shield Association (BCBSA), a national federation of 39 independent, community-based and locally operated Blue Cross and Blue Shield companies. He is also the Managing Director of BlueCross BlueShield Ventures, Inc., a $100 million strategic corporate venture fund formed by 11 Blue Cross and Blue Shield Plans to invest in emerging companies that will bring greater innovation, efficiency, consumer-focus and transparency to healthcare. 

Matt served as the first Chief Executive Officer of Morgan Street Document Systems. At Morgan Street he was instrumental in refining the strategy, establishing the initial business development relationships, and expanding the management team. Matt formerly worked in venture capital for Highland Capital Partners, a Boston-based VC firm with over $2 billion under management. Prior to Highland, he worked at Morgan Stanley in the Mergers and Acquisitions Group.